Filing Flows › Biolife Solutions (BLFS) › Q1 2026 › vs Q1 2025
Biolife Solutions (BLFS) Q1 2026 vs Q1 2025 (year over year)
Biolife Solutions's revenue rose $5.4M (+25%) from $22.1M in Q1 2025 to $27.5M in Q1 2026. Gross margin 63.6% against 67.1% (-3.5 pts).
Biolife Solutions, Q1 2026: revenue $27.5M (+25% year over year), operating margin 0.1%, net earnings $1.2M, operating cash flow −$491K. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Gross margin | 63.6% | 67.1% | -3.5 pts |
| Operating margin | 0.1% | -2.3% | +2.4 pts |
| Net margin | 4.3% | -2.0% | +6.3 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $27.5M | $22.1M | $5.4M | +25% |
| Gross profit | $17.5M | $14.8M | $2.7M | +18% |
| Cost of revenue | $10.0M | $7.3M | $2.8M | +38% |
| Other income, net | $1.2M | $65K | $1.2M | 19× |
| Operating profit | $27K | −$499K | $526K | — |
| Operating expenses | $17.5M | $15.3M | $2.2M | +14% |
| Pre-tax earnings | $1.2M | −$434K | $1.7M | — |
| Research & development | $2.6M | $1.4M | $1.2M | +84% |
| Sales & marketing | $2.5M | $2.4M | $83K | +3% |
| General & admin | $12.2M | $11.4M | $857K | +8% |
| Other operating costs | $85K | $66K | $19K | +29% |
| Net earnings | $1.2M | −$448K | $1.6M | — |
| Income tax | $62K | $14K | $48K | +343% |
| Operating cash sources | $6.9M | $2.7M | $4.2M | +158% |
| Depreciation & amortization | $374K | $682K | −$308K | -45% |
| Share-based compensation | $4.8M | $4.2M | $653K | +16% |
| Cash used in operations | $491K | −$1.7M | $2.2M | — |
| Working capital & other | $6.9M | $2.7M | $4.2M | +158% |
Questions
How much did Biolife Solutions's revenue grow year over year in Q1 2026?
Biolife Solutions's revenue rose $5.4M (+25%) from $22.1M in Q1 2025 to $27.5M in Q1 2026. Gross margin 63.6% against 67.1% (-3.5 pts).